Roche returns with super-tight 10yr
Hoffmann-La Roche, the Swiss pharmaceutical and medical diagnostics group, on Wednesday launched its first public euro bond since 2012, and achieved remarkably tight pricing.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
